Supported by Key Research and Development(R&D)Projects of Shanxi Province(No.201803D31095)。
AIM:To observe and characterize imaging features of macular and optic disc areas in less than 60-year-old patients with early primary open angle glaucoma(POAG)by optical coherence tomography(OCT)and optical coherence ...
Supported by the Key Laboratory Program of Shandong Eye Institute(No.2014-1);Medicine Science and Technology Development Program,Shandong,China(No.2015WS0204);the Science and Technology plan of Qingdao,China(No.15-9-1-35-jch);the Innovation Project of Shandong Academy of Medical Sciences
AIM: To compare the long-term outcomes of the Ex-PRESS miniature glaucoma device implanted under a scleral flap in combination of phacoemulsification with intraocular lens implantation in primary open angle glaucoma ...
Supported by the National Natural Science Foundation of China(No.81670847;No.81600728);the Science and Technology Program of Guangzhou,China(No.15570001)
AIM: To compare the outcomes of Ex-PRESS implantation in one eye versus trabeculectomy with mitomycin C in the fellow eye in Chinese patients with primary open-angle glaucoma (POAG). METHODS: This was a prospectiv...
Approximately 10% of UK blindness registrations are attributed to glaucoma . The risk of glaucoma increases with age and it is estimated that the prevalence of chronic open angle glaucoma (COAG) is about 10% in whit...
AIM:To evaluate the long-term response to the fixed combination of dorzolamide/timolol in patients with primary open angle glaucoma(POAG)and the addition of other intraocular pressure(IOP)lowering medications such as ...